Disposition of human drug preparations in the horse. V. Orally administered oxprenolol

Biomed Chromatogr. 1996 Jul-Aug;10(4):172-8. doi: 10.1002/(SICI)1099-0801(199607)10:4<172::AID-BMC588>3.0.CO;2-1.

Abstract

Urinary concentrations of the beta-antagonist oxprenolol and some of its major human metabolites were determined following oral administration of a dose of 160 mg to five fasted horses. Quantitation was performed by gas chromatography-mass spectrometry (GC-MS) in the selected ion mode (SIM) by monitoring ion m/z 466 of the heptafluorobutyric derivatives. As early as 2 h after dosage oxprenolol could be detected in hydrolysed urine and remained detectable up to 24 h. Maximum urinary concentrations and excretion rates were obtained between 2 and 12 h. After 12 h only 2.8% of the administered dose was excreted as conjugates of oxprenolol and major human metabolites including 4-OH-oxprenolol and 5-OH-oxprenolol. These metabolites were detectable up to 48 h.

MeSH terms

  • Administration, Oral
  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / chemistry
  • Adrenergic beta-Antagonists / pharmacokinetics*
  • Adrenergic beta-Antagonists / urine
  • Animals
  • Arylsulfatases / metabolism
  • Fasting
  • Female
  • Fluorocarbons / chemistry
  • Gas Chromatography-Mass Spectrometry / veterinary
  • Glucuronidase / metabolism
  • Horses / metabolism*
  • Humans
  • Hydrolysis
  • Indicators and Reagents / chemistry
  • Oxprenolol / administration & dosage
  • Oxprenolol / chemistry
  • Oxprenolol / pharmacokinetics*
  • Oxprenolol / urine
  • Reference Values

Substances

  • Adrenergic beta-Antagonists
  • Fluorocarbons
  • Indicators and Reagents
  • heptafluorobutyric anhydride
  • Oxprenolol
  • Arylsulfatases
  • Glucuronidase